We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and Lilly as a 2024 Marketing and Awareness Ambassador Level Impact Partner and a 2024-25 Patient Education Webinar Series Partner. This collaboration, with Lilly’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy. Collaboration for Impact with Our New […]
We are thrilled to announce Regenesis as a Champion Level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial in advancing our mission. Regenesis is a device company dedicated to improving human welfare through the research, design, manufacture, and sale of energy-based medical products and services that alleviate pain to improve quality of life. […]
Read More… from Announcing Our Renewed Partnership with Regenesis
We are thrilled to announce CSL Behring as a Champion level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial in advancing our mission. CSL Behring is a global leader in biotherapeutics, dedicated to improving the quality of life for patients with rare and serious diseases. By partnering with FPN, […]
Read More… from Announcing Our Renewed Partnership with CSL Behring
We are honored to announce that on May 16, 2024, the Foundation for Peripheral Neuropathy (FPN) received an extraordinary and transformational donation of over $660,000. This unprecedented gift, given posthumously, is the largest single contribution in our organization’s history. While the donor has chosen to remain anonymous, we wish to honor and celebrate their remarkable generosity. This substantial gift will […]
Read More… from The Foundation for Peripheral Neuropathy Receives Largest Gift to Date
We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and GlaxoSmithKline (GSK) as a 2024 Research Impact Partner. This collaboration, with GSK’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy. Expanding our reach Since our establishment in 2007, FPN has been dedicated to serving […]
Read More… from Announcing Our New Partnership with GlaxoSmithKline (GSK)
The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Johnson & Johnson, one of the world’s leading healthcare companies, as an esteemed 2024 Ambassador Impact Partner. This collaboration marks a significant milestone in FPN’s mission to advance research and education for individuals affected by peripheral neuropathy (PN). Collaboration for […]
Through the generosity of our donors, the Foundation for Peripheral Neuropathy (FPN) was able to support the IMAGiNe study with a $165,000 research grant to fund new patient enrollment for anti-MAG neuropathy. $90,000 of these funds were spent in 2022, which resulted in over 150 new patients enrolling in the study. In 2023, an additional $24,750 was spent, […]
Read More… from FPN Funds IMAGiNe Study for anti-MAG Research
The Foundation for Peripheral Neuropathy (FPN) welcomes Dr. David Bennett, MB, PhD, to the Foundation’s Scientific Advisory Board (SAB), effective November 2023. The SAB advises both the Board of Directors and staff of the Foundation on matters related to science and technology relevant to peripheral neuropathy and its research. About Dr. David Bennett Dr. David […]
The Foundation for Peripheral Neuropathy is pleased to welcome its newest Board Director, Dr. Gregory Maassen, PhD, effective January 1, 2023. About Dr. Gregory Maassen Dr. Gregory Maassen is a multimedia, strategic digital marketing, videographer, and (interim) manager. He has over 23 years of experience. This includes 18 years of senior management experience with the […]
Through the generosity of our donors, we’re able to support the IMAGiNe study with a $150,000 research grant to fund new patient enrollment. $90,000 of these funds, spent in 2022, resulted in over 150 new patients enrolling in the study. The IMAGiNe Study The IMAGiNe study is an international research collaborative focused on patients with […]
Read More… from FPN Funding Contributes $90,000 to IMAGiNe Study for anti-MAG Research